Latest filingSep 04, 2026Most recent Form 4
NTRA
Natera, Inc.
NasdaqHealthcareServices-Medical Laboratories
Insider activity for last month from 08/05 to 09/05. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$855M6 sells
Net open-market-$855M3 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period7transactions
- S · Open-market sells · dominant6 · 86%
- A · Grants / awards1 · 14%
Activity by reported role
A joint filing can contribute to multiple roles10transactions
- PRES · dominant7 · 70%
- CBO2 · 20%
- Chief executive officer1 · 10%
Distinct insiders active
Reporting-owner CIKs by month · peak Sep 2026 (2)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeMoshkevich SolomonCommon Stock · Direct
110,859Sep 02, 2026
Fesko JohnCommon Stock · Direct
197,257Aug 10, 2026
Chapman Steven LeonardCommon Stock · Direct
98,199Sep 01, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 05 → Sep 05
LessMore
Top insiders
By absolute net value across the selected period- MS-$5.9M
- FJ-$2.1M
- CL-$545.0k
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
NTRA transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| NTRA | Moshkevich Solomon | PRES | sale10b5-1 | 15.1k | -$495M | S | — | 0.0% | 09/04 | 09/02 |
| NTRA | Moshkevich Solomon | PRES | sale10b5-1 | 600 | -$19.3M | S | — | 0.0% | 09/04 | 09/01 |
| NTRA | Moshkevich Solomon | PRES | sale10b5-1 | 1.40k | -$44.9M | S | — | 0.0% | 09/04 | 09/01 |
| NTRA | Moshkevich Solomon | PRES | sale10b5-1 | 1.00k | -$31.9M | S | — | 0.0% | 09/04 | 09/01 |
| NTRA | Chapman Steven Leonard | CEOPRES | sale10b5-1 | 1.69k | -$54.5M | S | — | 0.0% | 09/04 | 09/01 |
| NTRA | Fesko John | PRESCBO | sale10b5-1 | 6.51k | -$209M | S | 0.0% | 08/29 | 08/10 | |
| NTRA | Fesko John | PRESCBO | grant10b5-1 | 20.0k | $0 | A | 0.0% | 08/29 | 08/06 |
Natera, Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Natera, Inc.?
Moshkevich Solomon, Chapman Steven Leonard, Fesko John.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Moshkevich Solomon reported a sale on Sep 02, 2026 valued at $495M. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $8,558,358.79. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.